No Data
No Data
Deutsche Bank Upgrades Boston Scientific(BSX.US) to Buy Rating, Raises Target Price to $108
Express News | Boston Scientific : Deutsche Bank Raises Target Price to $108 From $87
Medical PET Patent Landscape Report 2025, Covering 1,408 Patents Filed From 2010 to 2024 - ResearchAndMarkets.com
This week's U.S. stock market winners | The technology event CES ignited stock prices! Micron Technology rose over 10% during the week; is the pullback a buying opportunity? The second-hand car platform Carvana saw a rebound this week.
This week, the Dow Jones Industrial Average decreased by 0.23%, closing at 42,635.2 points; during the same period, the S&P 500 Index fell by 0.41%, closing at 5,918.25 points; the Nasdaq fell by 0.73%, closing at 19,478.88 points.
Truist Financial Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $110
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $95 to $110